Efficacy and Safety of Hetrombopag in Non-severe Aplastic Anemia

NCT05018936 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Aplastic Anemia
Drug Effect

Interventions

DRUG: Hetrombopag

Sponsor

Peking Union Medical College Hospital